aod9604 use AOD9604 2mg
Description
Where Phase I or Phase II human trials exist, they are noted in the compound page summary
this effect may be due to interference with erythrocyte maturation
Understanding why this occursfrom metabolic adjustment and nutrient demands to injection site reactionshelps distinguish expected responses from complications requiring medical attention
Elderly patients tend to have a greater frequency of decreased hepatic, renal, or cardiac function, and also have concomitant disease or receiving other drug therapy
